Therapeutic use of Aldara in chronic myeloid leukemia.
1/1/2007 J Transl Med. 2007 Jan 25;5:4 Marleau AM, Lipton JH, Riordan NH, Ichim TE. The potent clinical responses seen in patients with chronic myeloid leukemia (CML) after administration of donor-specific lymphocytes, as well as the correlation between the presence of antigen specific T cells and prolonged remission in these patients, suggests a role for…